Impact of complete molecular response on survival in patients with Philadelphia chromosome–positive acute lymphoblastic leukemia

The impact of achieving complete molecular response (CMR) in Philadelphia chromosome-positive (Ph(+)) acute lymphoblastic leukemia (ALL) remains undefined. We evaluated the impact of CMR on outcomes among 85 patients with Ph(+) ALL who received first-line hyperfractionated cyclophosphamide, vincrist...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Blood
Asıl Yazarlar: Short, Nicholas J., Jabbour, Elias, Sasaki, Koji, Patel, Keyur, O’Brien, Susan M., Cortes, Jorge E., Garris, Rebecca, Issa, Ghayas C., Garcia-Manero, Guillermo, Luthra, Rajyalakshmi, Thomas, Deborah, Kantarjian, Hagop, Ravandi, Farhad
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Society of Hematology 2016
Konular:
Clinical Trials and Observations
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4965905/
https://ncbi.nlm.nih.gov/pubmed/27235138
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2016-03-707562
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller